Literature DB >> 2166670

Hepatic scintigraphic changes associated with gestational trophoblastic disease.

E H Sumers1, R S Berkowitz, A M Wang, D E Drum, D P Goldstein.   

Abstract

We reviewed the results of radionuclide liver imaging in 70 patients newly referred for evaluation and treatment of persistent gestational trophoblastic tumors. Some 58 patients (83%) had abnormal liver scans but no focal defects and no discernible hepatic malignancy. These diffusely abnormal scans may reflect chemotherapeutic and/or hormonal effects on the liver and should not be interpreted as indicative of metastases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166670     DOI: 10.1007/BF00998178

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Treatment of metastatic trophoblastic disease: good and poor prognosis.

Authors:  C B Hammond; L G Borchert; L Tyrey; W T Creasman; R T Parker
Journal:  Am J Obstet Gynecol       Date:  1973-02-15       Impact factor: 8.661

2.  Methotrexate in rheumatoid arthritis.

Authors:  J H Klippel; J L Decker
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

3.  Scintigraphic criteria for hepatic metastases from cancer of the colon and breast.

Authors:  D E Drum; J M Beard
Journal:  J Nucl Med       Date:  1976-08       Impact factor: 10.057

4.  Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management.

Authors:  D P Goldstein; R S Berkowitz
Journal:  Major Probl Obstet Gynecol       Date:  1982

5.  Choriocarcinoma metastatic to the brain: therapy and prognosis.

Authors:  J C Weed; K T Woodward; C B Hammond
Journal:  Semin Oncol       Date:  1982-06       Impact factor: 4.929

6.  Liver scintigraphic features associated with alcoholism.

Authors:  D E Drum; J O Beard
Journal:  J Nucl Med       Date:  1978-02       Impact factor: 10.057

7.  Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.

Authors:  R S Berkowitz; D P Goldstein; M R Bernstein
Journal:  Cancer       Date:  1982-11-15       Impact factor: 6.860

8.  Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital.

Authors:  A Athanassiou; R H Begent; E S Newlands; D Parker; G J Rustin; K D Bagshawe
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

9.  Efficacy of low-dose methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; D A Fox; P A Fraser; D E Holdsworth; D N Glass; D E Trentham
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

10.  Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate.

Authors:  B M Flynn; S T Treves
Journal:  J Nucl Med       Date:  1987-04       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.